CD4 c.1289A>G ;(p.E430G)

Variant ID: 12-6928023-A-G

NM_000616.4(CD4):c.1289A>G;(p.E430G)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Development of Effective Siglec-9 Antibodies Against Cancer.

Current Oncology Reports
Wang, Jun Hui Shawn JHS; Jiang, Nan N; Jain, Amit A; Lim, Jackwee J
Publication Date: 2022-11-29

Variant appearance in text: CD4: E430G
PubMed Link: 36445569
Variant Present in the following documents:
  • 11912_2022_Article_1347.pdf
View BVdb publication page



Logic-gated antibody pairs that selectively act on cells co-expressing two antigens.

Nature Biotechnology
Oostindie, Simone C SC; Rinaldi, Derek A DA; Zom, Gijs G GG; Wester, Michael J MJ; Paulet, Desiree D; Al-Tamimi, Kusai K; van der Meijden, Els E; Scheick, Jennifer R JR; Wilpshaar, Tessa T; de Jong, Bart B; Hoff-van den Broek, Marloes M; Grattan, Rachel M RM; Oosterhoff, Janita J JJ; Vignau, Julie J; Verploegen, Sandra S; Boross, Peter P; Beurskens, Frank J FJ; Lidke, Diane S DS; Schuurman, Janine J; de Jong, Rob N RN
Publication Date: 2022-10

Variant appearance in text: CD4: E430G
PubMed Link: 35879362
Variant Present in the following documents:
  • 41587_2022_Article_1384.pdf
View BVdb publication page



Avidity in antibody effector functions and biotherapeutic drug design.

Nature Reviews. Drug Discovery
Oostindie, Simone C SC; Lazar, Greg A GA; Schuurman, Janine J; Parren, Paul W H I PWHI
Publication Date: 2022-10

Variant appearance in text: CD4: E430G
PubMed Link: 35790857
Variant Present in the following documents:
  • Main text
  • 41573_2022_Article_501.pdf
View BVdb publication page



An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.

Nature Cancer
Chan, Sarah S; Belmar, Nicole N; Ho, Sun S; Rogers, Bryan B; Stickler, Marcia M; Graham, Michelle M; Lee, Eileen E; Tran, Ninian N; Zhang, Dong D; Gupta, Priyanka P; Sho, Mien M; MacDonough, Tracy T; Woolley, Andrew A; Kim, Han H; Zhang, Hong H; Liu, Wei W; Zheng, Pingping P; Dezso, Zoltan Z; Halliwill, Kyle K; Ceccarelli, Michele M; Rhodes, Susan S; Thakur, Archana A; Forsyth, Charles M CM; Xiong, Mengli M; Tan, Siu Sze SS; Iyer, Ramesh R; Lake, Marc M; Digiammarino, Enrico E; Zhou, Li L; Bigelow, Lance L; Longenecker, Kenton K; Judge, Russell A RA; Liu, Cassie C; Trumble, Max M; Remis, Jonathan P JP; Fox, Melvin M; Cairns, Belinda B; Akamatsu, Yoshiko Y; Hollenbaugh, Diane D; Harding, Fiona F; Alvarez, Hamsell M HM
Publication Date: 2022-03

Variant appearance in text: CD4: E430G
PubMed Link: 35256819
Variant Present in the following documents:
  • 43018_2022_Article_334.pdf
View BVdb publication page



Biology drives the discovery of bispecific antibodies as innovative therapeutics.

Antibody Therapeutics
Nie, Siwei S; Wang, Zhuozhi Z; Moscoso-Castro, Maria M; D'Souza, Paul P; Lei, Can C; Xu, Jianqing J; Gu, Jijie J
Publication Date: 2020-01

Variant appearance in text: CD4: E430G
PubMed Link: 33928225
Variant Present in the following documents:
  • Main text
View BVdb publication page



CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.

International Journal Of Molecular Sciences
Bobrowicz, Malgorzata M; Kubacz, Matylda M; Slusarczyk, Aleksander A; Winiarska, Magdalena M
Publication Date: 2020-12-15

Variant appearance in text: CD4: E430G
PubMed Link: 33333768
Variant Present in the following documents:
  • Main text
  • ijms-21-09531.pdf
View BVdb publication page



Creatine maintains intestinal homeostasis and protects against colitis.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Turer, Emre E; McAlpine, William W; Wang, Kuan-Wen KW; Lu, Tianshi T; Li, Xiaohong X; Tang, Miao M; Zhan, Xiaoming X; Wang, Tao T; Zhan, Xiaowei X; Bu, Chun-Hui CH; Murray, Anne R AR; Beutler, Bruce B
Publication Date: 2017-02-14

Variant appearance in text: CD4: E430G
PubMed Link: 28137860
Variant Present in the following documents:
  • Main text
View BVdb publication page